Background The literature regarding clinical olfaction, olfactory loss, and olfactory
dysfunction has expanded rapidly over the past two decades, with an exponential rise in the …

People with type 2 diabetes mellitus (T2DM) are at increased risk of mild cognitive
impairment and dementia. Systemic inflammation has been proposed as a common risk …

OBJECTIVE Large numbers of people with type 2 diabetes are obese. However, changes in
cognition and related brain function in obese people with diabetes have not been …

The olfactory system is at the crossroad between sensory processing and metabolic
sensing. In addition to being the center of detection and identification of food odors, it is a …

Recent data suggest that olfactory deficits could represent an early marker and a pathogenic
mechanism at the basis of cognitive decline in type 2 diabetes (T2D). However, research is …

Aim This study investigates the prevalence of smell and taste impairment in adults with
diabetes and potential risk factors for sense deterioration and its influence of daily food …

Background Evidence suggests that olfactory impairment (OI) may be a degenerative
neurologic complication of diabetes; however, the association is not yet well established …

Aims We aimed to identify alterations in global gray matter volumes (GMV) and consistent
regional abnormalities in T2DM patients via meta-analysis. Methods A systematic search for …

Objective We aim to quantify the co-existence of age-related macular degeneration (AMD),
glaucoma, or diabetic retinopathy (DR) and cognitive impairment or dementia. Method …

The increasing global prevalence of diabetes mellitus presents a significant challenge to
healthcare systems today. Although diabetic retinopathy, nephropathy and neuropathy are …